Clinical factors associated with major poor outcomes in kidney transplant recipients with cutaneous squamous cell carcinomas
Published: 29 April 2026| Version 1 | DOI: 10.17632/xy67d2cztn.1
Contributors:
Mayra Betancourt Ponce, Annika WeinhammerDescription
Supplementary Figure 1. Timeline of chemoprevention and immunosuppressive agents use and post-transplant events by subject. Supplementary Table 1. Demographic and tumor characteristics of kidney transplant recipients with cutaneous SCC-related major poor outcomes.
Files
Categories
Organ Transplantation, Immunosuppression, Squamous Cell Carcinoma